MPCI fundamentals
An in-depth look to MEMPHIS PHARMACEUTICALS operating, investing, and financing activities
MPCI free cash flow for Q2 24 is 105.35 M EGP. For 2023, MPCI free cash flow was 57.36 M EGP and operating cash flow was 68.81 M EGP.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM